RecruitingNot ApplicableNCT06185829

Evaluating the Benefit of Hypnoanalgesia Versus Neuroleptanalgesia During Hand Surgery

Sponsor

GCS Ramsay Santé pour l'Enseignement et la Recherche

Enrollment

64 participants

Start Date

Oct 19, 2023

Study Type

INTERVENTIONAL

Conditions

hand surgery

Summary

This is a single-center, prospective, randomized, open-label study of two parallel groups of patients undergoing hand surgery: Group 1: locoregional anesthesia + neuroleptanalgesia Group 2: locoregional anesthesia + hypnoanalgesia Therapeutic benefit is based on VAS assessment of intraoperative anxiety.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Hypnoanalgesia and a drug called Neuroleptanalgesic treatment for people with hand surgery. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGNeuroleptanalgesic treatment

Usual neuroleptanalgesic treatment Hypnovel and Locoregional anesthesia

OTHERHypnoanalgesia

Hypnoanalgesia and Locoregional anesthesia

Locations(1)

Hôpital Privé Paul d'Egine

Champigny-sur-Marne, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06185829

Related Trials

Comparison of Conventional and Retroclavicular Approaches for Ultrasound-guided Infraclavicular Brachial Plexus Block

NCT071514431 location